Published in FEMS Microbiol Lett on February 01, 2005
Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy. PLoS One (2012) 1.08
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains. Antimicrob Agents Chemother (2010) 1.01
Cyclic AMP in mycobacteria: characterization and functional role of the Rv1647 ortholog in Mycobacterium smegmatis. J Bacteriol (2008) 0.99
Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosis. Antimicrob Agents Chemother (2014) 0.83
Highly fluorescent GFPm 2+ -based genome integration-proficient promoter probe vector to study Mycobacterium tuberculosis promoters in infected macrophages. Microb Biotechnol (2011) 0.76
An accurate method for the qualitative detection and quantification of mycobacterial promoter activity. Open Microbiol J (2013) 0.75
Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol (2002) 5.73
Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redox-dependent signaling. PLoS Pathog (2010) 1.79
Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol (2003) 1.54
Mycobacterium tuberculosis produces pili during human infection. Proc Natl Acad Sci U S A (2007) 1.50
Mesh erosion in robotic sacrocolpopexy. Female Pelvic Med Reconstr Surg (2012) 1.34
Complications associated with transobturator sling procedures. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.28
Expression, production and release of the Eis protein by Mycobacterium tuberculosis during infection of macrophages and its effect on cytokine secretion. Microbiology (2007) 1.26
Burkholderia cepacia: This Decision Is Overdue. PDA J Pharm Sci Technol (2012) 1.01
Molecular characterization of the eis promoter of Mycobacterium tuberculosis. J Bacteriol (2004) 1.01
Functions of the cytoplasmic exosome. Adv Exp Med Biol (2011) 0.99
Positive inotropic effects of low dATP/ATP ratios on mechanics and kinetics of porcine cardiac muscle. Biophys J (2006) 0.97
"The cough game": are there characteristic urethrovesical movement patterns associated with stress incontinence? Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.92
Effects of rapamycin on cardiac and skeletal muscle contraction and crossbridge cycling. J Pharmacol Exp Ther (2004) 0.90
Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition. Breast Cancer Res Treat (2014) 0.88
Functions of the cytoplasmic exosome. Adv Exp Med Biol (2010) 0.86
Levator myalgia: why bother? Int Urogynecol J (2013) 0.83
An occupation-based strategy training approach to managing age-related executive changes: a pilot randomized controlled trial. Clin Rehabil (2013) 0.82
Determining in vivo activity of the yeast cytoplasmic exosome. Methods Enzymol (2008) 0.80
The presacral space and its impact on sacral neuromodulator implantation. J Urol (2008) 0.78
Patient information: Part 2. Planning an information package. Prof Nurse (2003) 0.78
Tension-Free Vaginal Tape Failure After Robotic Sacrocolpopexy and Tension-Free Vaginal Tape for Concomitant Prolapse and Stress Incontinence. Female Pelvic Med Reconstr Surg (2015) 0.77
Lost in translation? Psychometric properties and construct validity of the English Essen Climate Evaluation Schema (EssenCES) social climate questionnaire. Psychol Assess (2011) 0.77
Protocol-based care: 1. How integrated care pathways work. Prof Nurse (2003) 0.76
Bordetella bronchiseptica responses to physiological reactive nitrogen and oxygen stresses. FEMS Microbiol Lett (2008) 0.75
The psychological impact of living with skin disease. Prof Nurse (2003) 0.75
A unique case of recurrent metachronous volvulus of the gastrointestinal tract. Arch Surg (2009) 0.75
Patient information: Part 4. Content and presentation. Prof Nurse (2004) 0.75
Patient information: Part 5. Quality standards and evaluation. Prof Nurse (2004) 0.75
Microbial Risk in Pharmaceutical Manufacturing and ICH Q9. PDA J Pharm Sci Technol (2013) 0.75
Consumption of beverages and health. Prof Nurse (2003) 0.75
Explaining Student Interest and Confidence in Providing Care for Older Adults: The Role of Demographics and Life Experiences. J Gerontol Nurs (2016) 0.75
Hemodynamic Findings of Severe Subacute Aortic Regurgitation. J Invasive Cardiol (2017) 0.75
How will health-care organizations meet venous thromboembolism targets? Br J Hosp Med (Lond) (2011) 0.75
Vitamins. Prof Nurse (2003) 0.75
Give us the tools and we will finish the job. Prof Nurse (2003) 0.75
Author response. PDA J Pharm Sci Technol (2012) 0.75
Diuretics. Prof Nurse (2002) 0.75
SARS: current advice and information for would-be travellers. Prof Nurse (2003) 0.75